Analysis of Plasma Epstein–Barr Virus <scp>DNA</scp> and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in <scp>KEYNOTE</scp> ‐122
Authors
Sung‐Bae Kim
Ramona F. Swaby
Andrea L. Webber (ORCID: https://orcid.org/0000-0003-2463-0878)
Analysis of Plasma Epstein–Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE ‐122
Sung‐Bae Kim, Ramona F. Swaby, Andrea L. Webber, Burak Gümüşçü et al.
Journal
Cancer Medicine
Topics
Head and Neck Cancer Studies
article
Analysis of Plasma Epstein–Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE ‐122
Sung‐Bae Kim, Ramona F. Swaby, Andrea L. Webber, Burak Gümüşçü, Nuttapong Ngamphaiboon, Ruey‐Long Hong, Priscilla B. Caguioa, Anna Spreafico, Jianda Yuan, Anthony T C Chan, John Kang, Lillian L. Siu, Gwo Fuang Ho, Bo Wei, Victor Ho Fun Lee, Myung‐Ju Ahn, Wan Qin Chong
article en
Abstract
No abstract available for this paper.
Publication Tag
Cancer MedicineVol. 15(2)
Institutions
University of Santo Tomas Hospital (PH), Merck & Co., Inc., Rahway, NJ, USA (United States) (US), National Taiwan University (TW), Chinese University of Hong Kong (HK), University of Toronto (CA), Mahidol University (TH), Samsung Medical Center (KR), Princess Margaret Cancer Centre (CA), University of Malaya (MY), University of Ulsan (KR), National University Cancer Institute, Singapore (SG), Ramathibodi Hospital (TH), University of Santo Tomas (PH), University of Hong Kong (HK)